Asia-Pacific biologics market is estimated to grow at a CAGR of 9.2% during the forecast period. Some pivotal factors accelerating market growth include the rising prevalence of cancer and increasing launches of biologics therapy. As per the World Health Organization (WHO), in Asia, the number of new cancer incidences expected to be reported in 2020 […]
